360iResearch Logo
Global Active Pharmaceutical Ingredient Market
Report Code: MRR-2AA0F85 | Publishing Date: April 2020 | Number of Pages: 170

Global Active Pharmaceutical Ingredient Market | Market Research Report | Cumulative Impact of COVID-19

The Global Active Pharmaceutical Ingredient Market to grow from USD xx.xx Million in 2019 to USD xx.xx Million by 2025, at a Compound Annual Growth Rate (CAGR) of xx.xx%. Some of the major market players include Abbvie Inc., Astrazeneca, Aurobindo Pharma, BASF SE, and Boehringer Ingelheim.

Global Active Pharmaceutical Ingredient Market | Market Research Report | Cumulative Impact of COVID-19

Market Dynamics:

The factors attributing to the growth of the market are adoption of ai-based tools and organ-on-chip models in drug discovery & development, technological advancements in active pharmaceutical ingredients, increasing incidences of chronic diseases, growing importance of generics coupled with uptakes of biopharmaceuticals, and rising focus on precision medicine and growing investment. However, some factors such as increasing availability of counterfeit drugs and unsupportive price control policies for drug across various countries may hinder the market growth. The Active Pharmaceutical Ingredient Market is expected to showcase the opportunities such as highly effective active pharmaceutical ingredients and emergence of biosimilars. In the near future market may face the possible challenges in the growth due to concern associated with the product differentiation and high cost associated with the manufacturing process. However, the key players in the market are putting regressive efforts to provide innovative offerings and benchmark strategies in the Active Pharmaceutical Ingredient Market.

Market Segmentation & Coverage:

The research report categorizes the Active Pharmaceutical Ingredient Market to forecast the revenues and analyze the trends in each of the following segments:

On the basis of Type, the Active Pharmaceutical Ingredient Market is studied across Generic Active Pharmaceutical Ingredients and Innovative Active Pharmaceutical Ingredients.

On the basis of Manufacturer, the Active Pharmaceutical Ingredient Market is studied across Captive API Manufacturers and Merchant API Manufacturers. The Merchant API Manufacturers further studied across Merchant Biotech API Manufacturers, Merchant Generic API Manufacturers, Merchant Innovative API Manufacturers, and Merchant Synthetic API Manufacturers.

On the basis of Synthesis, the Active Pharmaceutical Ingredient Market is studied across Biotech Active Pharmaceutical Ingredients and Synthetic Active Pharmaceutical Ingredients.

On the basis of Therapeutic Application, the Active Pharmaceutical Ingredient Market is studied across Cardiovascular Diseases, Communicable Diseases, Diabetes, Oncology, Pain Management, and Respiratory Diseases.

On the basis of Geography, the Active Pharmaceutical Ingredient Market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas region is studied across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific region is studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa region is studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Company Usability Profiles:

The Active Pharmaceutical Ingredient Market is highly competitive and characterized by the presence of a large number of international and regional players in the market. The market has witnessed increasing competition between vendors based on the pricing model, technology differentiation, brand name, quality of service, price differentiation, and technical expertise.

The Active Pharmaceutical Ingredient Market research report provides the company usability profiles and analyze the overview, strategy, SWOT and scorecard of the following company:

  • Abbvie Inc.
  • Astrazeneca
  • Aurobindo Pharma
  • BASF SE
  • Boehringer Ingelheim
  • Bristol-Myers Squibb
  • ELI Lilly and Company
  • F. Hoffmann-La Roche
  • Glaxosmithkline PLC
  • Merck & Co., Inc.
  • Novartis AG
  • Pfizer, Inc.
  • Sanofi
  • Sun Pharmaceutical Industries Ltd
  • Teva Pharmaceutical Industries Ltd

Scope of the Report:

AttributeDetails
Base Year for Estimation2019
Historical Period2017 - 2018
Estimation Period2020 - 2021
Forecast Year2025
Market RepresentationRevenue in USD Million
Report CoverageRevenue Forecast, Company Share, Competitive Landscape, and Industry Trends.
Customization ScopeIf you need specific market information, which is not currently within the scope of the report, we will provide it to you as a part of customization. We offer 20% free customization which is equivalent to 5 analysts working days.

Report Highlights:

The report provides deep insights on demand forecasts, market trends and micro and macro indicators. In addition, this report provides insights on the factors that are driving and restraining the demand of the Active Pharmaceutical Ingredient Market. Moreover, the study highlights current market trends and provides forecast. We also have highlighted future trends in the Active Pharmaceutical Ingredient Market that will impact the demand during the forecast period. Moreover, the competitive analysis of the Active Pharmaceutical Ingredient Market brings an insight on the company usability profiles of the leading players. Additionally, the analysis highlights business overview, strategy, and SWOT analysis of the key companies in the market.

Reasons to Buy:

The Active Pharmaceutical Ingredient Market research study reveals hidden insights and dynamic, which in turn helps the players in the ecosystem take better strategic decisions. The firms looking for purchasing the Active Pharmaceutical Ingredient Market research report could look for following prospects on their way to better understand the market that can aid further decision making and possibly identify the best opportunities to exploit.

  • Evaluate the qualitative and quantitative aspects of the report and analyze the Active Pharmaceutical Ingredient Market penetration with respect to industries and geographies.
  • Evaluates the key vendors and deeply analyze competitive landscape, revenue pockets, market trends, growth prospects, pain points, drivers, restraints, challenges and opportunities of the Active Pharmaceutical Ingredient Market .
  • Evaluate the key vendors in the Active Pharmaceutical Ingredient Market in terms of products satisfaction and business strategy. This helps identify consumer preferences and understand its current position in 360iResearch FPNV Positioning Matrix.
  1. Preface
    1. Objectives of the Study
    2. Market Segmentation & Coverage
    3. Years Considered for the Study
    4. Currency & Pricing
    5. Language
    6. Stakeholders
  2. Research & Forecasting
    1. Research Methodology
    2. Forecasting Methodology
  3. Executive Summary
    1. Market Outlook
    2. Geography Outlook
    3. Competitor Outlook
  4. Market Overview
    1. Introduction
    2. Active Pharmaceutical Ingredient Market, By Geography
    3. Active Pharmaceutical Ingredient Market, By Type
    4. Active Pharmaceutical Ingredient Market, By Manufacturer
    5. Active Pharmaceutical Ingredient Market, By Synthesis
    6. Active Pharmaceutical Ingredient Market, By Therapeutic Application
  5. Market Dynamics
    1. Introduction
    2. Drivers
      1. Increasing incidences of chronic diseases
      2. Growing importance of generics coupled with uptakes of biopharmaceuticals
      3. Technological advancements in active pharmaceutical ingredients
      4. Adoption of AI-based tools and organ-on-chip models in drug discovery & development
      5. Rising focus on precision medicine and growing investment
    3. Restraints
      1. Unsupportive price control policies for drug across various countries
      2. Increasing availability of counterfeit drugs
    4. Opportunities
      1. Emergence of biosimilars
      2. Highly effective active pharmaceutical ingredients
    5. Challenges
      1. High cost associated with the manufacturing process
      2. Concern associated with the product differentiation
  6. Industry Trends
    1. Porters Five Forces Analysis
      1. Threat of New Entrants
      2. Threat of Substitutes
      3. Bargaining Power of Customers
      4. Bargaining Power of Suppliers
      5. Industry Rivalry
    2. Cumulative Impact of COVID-19
    3. Client Customizations
      1. Market Ecosystem
  7. Active Pharmaceutical Ingredient Market, By Type
    1. Introduction
    2. Generic Active Pharmaceutical Ingredients
    3. Innovative Active Pharmaceutical Ingredients
  8. Active Pharmaceutical Ingredient Market, By Manufacturer
    1. Introduction
    2. Captive API Manufacturers
    3. Merchant API Manufacturers
      1. Merchant Biotech API Manufacturers
      2. Merchant Generic API Manufacturers
      3. Merchant Innovative API Manufacturers
      4. Merchant Synthetic API Manufacturers
  9. Active Pharmaceutical Ingredient Market, By Synthesis
    1. Introduction
    2. Biotech Active Pharmaceutical Ingredients
    3. Synthetic Active Pharmaceutical Ingredients
  10. Active Pharmaceutical Ingredient Market, By Therapeutic Application
    1. Introduction
    2. Cardiovascular Diseases
    3. Communicable Diseases
    4. Diabetes
    5. Oncology
    6. Pain Management
    7. Respiratory Diseases
  11. Active Pharmaceutical Ingredient Market, By Americas
    1. Introduction
    2. Argentina
    3. Brazil
    4. Canada
    5. Mexico
    6. United States
  12. Active Pharmaceutical Ingredient Market, By Asia-Pacific
    1. Introduction
    2. Australia
    3. China
    4. India
    5. Indonesia
    6. Japan
    7. Malaysia
    8. Philippines
    9. South Korea
    10. Thailand
  13. Active Pharmaceutical Ingredient Market, By Europe, Middle East & Africa
    1. Introduction
    2. France
    3. Germany
    4. Italy
    5. Netherlands
    6. Qatar
    7. Russia
    8. Saudi Arabia
    9. South Africa
    10. Spain
    11. United Arab Emirates
    12. United Kingdom
  14. Competitive Landscape
    1. FPNV Positioning Matrix
    2. Market Vendor Ranking Analysis
    3. Competitive Scenario
      1. Merger & Acquisition
      2. Agreement, Collaboration & Partnership
      3. New Product Launch & Enhancement
      4. Investment & Funding
  15. Company Usability Profiles
    1. Abbvie Inc.
    2. Astrazeneca
    3. Aurobindo Pharma
    4. BASF SE
    5. Boehringer Ingelheim
    6. Bristol-Myers Squibb
    7. ELI Lilly and Company
    8. F. Hoffmann-La Roche
    9. Glaxosmithkline PLC
    10. Merck & Co., Inc.
    11. Novartis AG
    12. Pfizer, Inc.
    13. Sanofi
    14. Sun Pharmaceutical Industries Ltd
    15. Teva Pharmaceutical Industries Ltd
  16. Appendix
    1. Discussion Guide
    2. Edition Details
    3. License Details
    4. Pricing Details

List of Tables

  1. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET: SEGMENTATION & COVERAGE
  2. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, 2017-2025 (USD MILLION)
  3. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY TYPE, 2017-2025 (USD MILLION)
  4. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY GENERIC ACTIVE PHARMACEUTICAL INGREDIENTS, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  5. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY INNOVATIVE ACTIVE PHARMACEUTICAL INGREDIENTS, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  6. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY MANUFACTURER, 2017-2025 (USD MILLION)
  7. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY CAPTIVE API MANUFACTURERS, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  8. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY MERCHANT API MANUFACTURERS, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  9. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY MERCHANT BIOTECH API MANUFACTURERS, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  10. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY MERCHANT GENERIC API MANUFACTURERS, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  11. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY MERCHANT INNOVATIVE API MANUFACTURERS, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  12. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY MERCHANT SYNTHETIC API MANUFACTURERS, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  13. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY SYNTHESIS, 2017-2025 (USD MILLION)
  14. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  15. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY SYNTHETIC ACTIVE PHARMACEUTICAL INGREDIENTS, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  16. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY THERAPEUTIC APPLICATION, 2017-2025 (USD MILLION)
  17. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  18. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY COMMUNICABLE DISEASES, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  19. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY DIABETES, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  20. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY ONCOLOGY, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  21. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY PAIN MANAGEMENT, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  22. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY RESPIRATORY DISEASES, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  23. AMERICAS ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY COUNTRY, 2017-2025 (USD MILLION)
  24. AMERICAS ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY TYPE, 2017-2025 (USD MILLION)
  25. AMERICAS ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY MANUFACTURER, 2017-2025 (USD MILLION)
  26. AMERICAS ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY SYNTHESIS, 2017-2025 (USD MILLION)
  27. AMERICAS ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY THERAPEUTIC APPLICATION, 2017-2025 (USD MILLION)
  28. ARGENTINA ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY TYPE, 2017-2025 (USD MILLION)
  29. ARGENTINA ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY MANUFACTURER, 2017-2025 (USD MILLION)
  30. ARGENTINA ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY SYNTHESIS, 2017-2025 (USD MILLION)
  31. ARGENTINA ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY THERAPEUTIC APPLICATION, 2017-2025 (USD MILLION)
  32. BRAZIL ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY TYPE, 2017-2025 (USD MILLION)
  33. BRAZIL ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY MANUFACTURER, 2017-2025 (USD MILLION)
  34. BRAZIL ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY SYNTHESIS, 2017-2025 (USD MILLION)
  35. BRAZIL ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY THERAPEUTIC APPLICATION, 2017-2025 (USD MILLION)
  36. CANADA ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY TYPE, 2017-2025 (USD MILLION)
  37. CANADA ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY MANUFACTURER, 2017-2025 (USD MILLION)
  38. CANADA ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY SYNTHESIS, 2017-2025 (USD MILLION)
  39. CANADA ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY THERAPEUTIC APPLICATION, 2017-2025 (USD MILLION)
  40. MEXICO ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY TYPE, 2017-2025 (USD MILLION)
  41. MEXICO ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY MANUFACTURER, 2017-2025 (USD MILLION)
  42. MEXICO ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY SYNTHESIS, 2017-2025 (USD MILLION)
  43. MEXICO ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY THERAPEUTIC APPLICATION, 2017-2025 (USD MILLION)
  44. UNITED STATES ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY TYPE, 2017-2025 (USD MILLION)
  45. UNITED STATES ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY MANUFACTURER, 2017-2025 (USD MILLION)
  46. UNITED STATES ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY SYNTHESIS, 2017-2025 (USD MILLION)
  47. UNITED STATES ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY THERAPEUTIC APPLICATION, 2017-2025 (USD MILLION)
  48. ASIA-PACIFIC ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY COUNTRY, 2017-2025 (USD MILLION)
  49. ASIA-PACIFIC ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY TYPE, 2017-2025 (USD MILLION)
  50. ASIA-PACIFIC ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY MANUFACTURER, 2017-2025 (USD MILLION)
  51. ASIA-PACIFIC ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY SYNTHESIS, 2017-2025 (USD MILLION)
  52. ASIA-PACIFIC ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY THERAPEUTIC APPLICATION, 2017-2025 (USD MILLION)
  53. AUSTRALIA ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY TYPE, 2017-2025 (USD MILLION)
  54. AUSTRALIA ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY MANUFACTURER, 2017-2025 (USD MILLION)
  55. AUSTRALIA ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY SYNTHESIS, 2017-2025 (USD MILLION)
  56. AUSTRALIA ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY THERAPEUTIC APPLICATION, 2017-2025 (USD MILLION)
  57. CHINA ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY TYPE, 2017-2025 (USD MILLION)
  58. CHINA ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY MANUFACTURER, 2017-2025 (USD MILLION)
  59. CHINA ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY SYNTHESIS, 2017-2025 (USD MILLION)
  60. CHINA ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY THERAPEUTIC APPLICATION, 2017-2025 (USD MILLION)
  61. INDIA ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY TYPE, 2017-2025 (USD MILLION)
  62. INDIA ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY MANUFACTURER, 2017-2025 (USD MILLION)
  63. INDIA ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY SYNTHESIS, 2017-2025 (USD MILLION)
  64. INDIA ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY THERAPEUTIC APPLICATION, 2017-2025 (USD MILLION)
  65. INDONESIA ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY TYPE, 2017-2025 (USD MILLION)
  66. INDONESIA ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY MANUFACTURER, 2017-2025 (USD MILLION)
  67. INDONESIA ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY SYNTHESIS, 2017-2025 (USD MILLION)
  68. INDONESIA ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY THERAPEUTIC APPLICATION, 2017-2025 (USD MILLION)
  69. JAPAN ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY TYPE, 2017-2025 (USD MILLION)
  70. JAPAN ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY MANUFACTURER, 2017-2025 (USD MILLION)
  71. JAPAN ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY SYNTHESIS, 2017-2025 (USD MILLION)
  72. JAPAN ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY THERAPEUTIC APPLICATION, 2017-2025 (USD MILLION)
  73. MALAYSIA ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY TYPE, 2017-2025 (USD MILLION)
  74. MALAYSIA ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY MANUFACTURER, 2017-2025 (USD MILLION)
  75. MALAYSIA ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY SYNTHESIS, 2017-2025 (USD MILLION)
  76. MALAYSIA ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY THERAPEUTIC APPLICATION, 2017-2025 (USD MILLION)
  77. PHILIPPINES ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY TYPE, 2017-2025 (USD MILLION)
  78. PHILIPPINES ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY MANUFACTURER, 2017-2025 (USD MILLION)
  79. PHILIPPINES ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY SYNTHESIS, 2017-2025 (USD MILLION)
  80. PHILIPPINES ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY THERAPEUTIC APPLICATION, 2017-2025 (USD MILLION)
  81. SOUTH KOREA ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY TYPE, 2017-2025 (USD MILLION)
  82. SOUTH KOREA ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY MANUFACTURER, 2017-2025 (USD MILLION)
  83. SOUTH KOREA ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY SYNTHESIS, 2017-2025 (USD MILLION)
  84. SOUTH KOREA ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY THERAPEUTIC APPLICATION, 2017-2025 (USD MILLION)
  85. THAILAND ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY TYPE, 2017-2025 (USD MILLION)
  86. THAILAND ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY MANUFACTURER, 2017-2025 (USD MILLION)
  87. THAILAND ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY SYNTHESIS, 2017-2025 (USD MILLION)
  88. THAILAND ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY THERAPEUTIC APPLICATION, 2017-2025 (USD MILLION)
  89. EUROPE, MIDDLE EAST & AFRICA ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY COUNTRY, 2017-2025 (USD MILLION)
  90. EUROPE, MIDDLE EAST & AFRICA ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY TYPE, 2017-2025 (USD MILLION)
  91. EUROPE, MIDDLE EAST & AFRICA ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY MANUFACTURER, 2017-2025 (USD MILLION)
  92. EUROPE, MIDDLE EAST & AFRICA ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY SYNTHESIS, 2017-2025 (USD MILLION)
  93. EUROPE, MIDDLE EAST & AFRICA ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY THERAPEUTIC APPLICATION, 2017-2025 (USD MILLION)
  94. FRANCE ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY TYPE, 2017-2025 (USD MILLION)
  95. FRANCE ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY MANUFACTURER, 2017-2025 (USD MILLION)
  96. FRANCE ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY SYNTHESIS, 2017-2025 (USD MILLION)
  97. FRANCE ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY THERAPEUTIC APPLICATION, 2017-2025 (USD MILLION)
  98. GERMANY ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY TYPE, 2017-2025 (USD MILLION)
  99. GERMANY ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY MANUFACTURER, 2017-2025 (USD MILLION)
  100. GERMANY ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY SYNTHESIS, 2017-2025 (USD MILLION)
  101. GERMANY ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY THERAPEUTIC APPLICATION, 2017-2025 (USD MILLION)
  102. ITALY ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY TYPE, 2017-2025 (USD MILLION)
  103. ITALY ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY MANUFACTURER, 2017-2025 (USD MILLION)
  104. ITALY ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY SYNTHESIS, 2017-2025 (USD MILLION)
  105. ITALY ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY THERAPEUTIC APPLICATION, 2017-2025 (USD MILLION)
  106. NETHERLANDS ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY TYPE, 2017-2025 (USD MILLION)
  107. NETHERLANDS ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY MANUFACTURER, 2017-2025 (USD MILLION)
  108. NETHERLANDS ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY SYNTHESIS, 2017-2025 (USD MILLION)
  109. NETHERLANDS ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY THERAPEUTIC APPLICATION, 2017-2025 (USD MILLION)
  110. QATAR ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY TYPE, 2017-2025 (USD MILLION)
  111. QATAR ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY MANUFACTURER, 2017-2025 (USD MILLION)
  112. QATAR ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY SYNTHESIS, 2017-2025 (USD MILLION)
  113. QATAR ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY THERAPEUTIC APPLICATION, 2017-2025 (USD MILLION)
  114. RUSSIA ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY TYPE, 2017-2025 (USD MILLION)
  115. RUSSIA ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY MANUFACTURER, 2017-2025 (USD MILLION)
  116. RUSSIA ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY SYNTHESIS, 2017-2025 (USD MILLION)
  117. RUSSIA ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY THERAPEUTIC APPLICATION, 2017-2025 (USD MILLION)
  118. SAUDI ARABIA ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY TYPE, 2017-2025 (USD MILLION)
  119. SAUDI ARABIA ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY MANUFACTURER, 2017-2025 (USD MILLION)
  120. SAUDI ARABIA ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY SYNTHESIS, 2017-2025 (USD MILLION)
  121. SAUDI ARABIA ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY THERAPEUTIC APPLICATION, 2017-2025 (USD MILLION)
  122. SOUTH AFRICA ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY TYPE, 2017-2025 (USD MILLION)
  123. SOUTH AFRICA ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY MANUFACTURER, 2017-2025 (USD MILLION)
  124. SOUTH AFRICA ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY SYNTHESIS, 2017-2025 (USD MILLION)
  125. SOUTH AFRICA ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY THERAPEUTIC APPLICATION, 2017-2025 (USD MILLION)
  126. SPAIN ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY TYPE, 2017-2025 (USD MILLION)
  127. SPAIN ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY MANUFACTURER, 2017-2025 (USD MILLION)
  128. SPAIN ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY SYNTHESIS, 2017-2025 (USD MILLION)
  129. SPAIN ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY THERAPEUTIC APPLICATION, 2017-2025 (USD MILLION)
  130. UNITED ARAB EMIRATES ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY TYPE, 2017-2025 (USD MILLION)
  131. UNITED ARAB EMIRATES ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY MANUFACTURER, 2017-2025 (USD MILLION)
  132. UNITED ARAB EMIRATES ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY SYNTHESIS, 2017-2025 (USD MILLION)
  133. UNITED ARAB EMIRATES ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY THERAPEUTIC APPLICATION, 2017-2025 (USD MILLION)
  134. UNITED KINGDOM ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY TYPE, 2017-2025 (USD MILLION)
  135. UNITED KINGDOM ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY MANUFACTURER, 2017-2025 (USD MILLION)
  136. UNITED KINGDOM ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY SYNTHESIS, 2017-2025 (USD MILLION)
  137. UNITED KINGDOM ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY THERAPEUTIC APPLICATION, 2017-2025 (USD MILLION)
  138. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET: RANKING
  139. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET: BUSINESS STRATEGY
  140. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET: PRODUCT SATISFACTION
  141. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET: MERGER & ACQUISITION
  142. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET: AGREEMENT, COLLABORATION & PARTNERSHIP
  143. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
  144. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET: INVESTMENT & FUNDING
  145. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET: EDITION DETAILS
  146. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET: LICENSE DETAILS
  147. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET: PRICING DETAILS

List of Figures

  1. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET: RESEARCH PROCESS
  2. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET: RESEARCH FRAMEWORK
  3. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET: FORECASTING METHODOLOGY
  4. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY GEOGRAPHY, 2019 (USD MILLION)
  5. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET, BY TYPE
  6. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, 2017-2025 (USD MILLION)
  7. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY GEOGRAPHY, 2019 VS 2025 (USD MILLION)
  8. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY TYPE, 2019 VS 2025 (USD MILLION)
  9. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY MANUFACTURER, 2019 VS 2025 (USD MILLION)
  10. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY SYNTHESIS, 2019 VS 2025 (USD MILLION)
  11. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY THERAPEUTIC APPLICATION, 2019 VS 2025 (USD MILLION)
  12. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET: MARKET DYNAMICS
  13. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET: PORTERS FIVE FORCES ANALYSIS
  14. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET: CUMULATIVE IMPACT OF COVID-19
  15. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY TYPE, 2025 (USD MILLION)
  16. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET, BY GENERIC ACTIVE PHARMACEUTICAL INGREDIENTS SIZE, BY GEOGRAPHY, 2019 (USD MILLION)
  17. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET, BY INNOVATIVE ACTIVE PHARMACEUTICAL INGREDIENTS SIZE, BY GEOGRAPHY, 2019 (USD MILLION)
  18. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY MANUFACTURER, 2025 (USD MILLION)
  19. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET, BY CAPTIVE API MANUFACTURERS SIZE, BY GEOGRAPHY, 2019 (USD MILLION)
  20. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET, BY MERCHANT API MANUFACTURERS SIZE, BY GEOGRAPHY, 2019 (USD MILLION)
  21. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY SYNTHESIS, 2025 (USD MILLION)
  22. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET, BY BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS SIZE, BY GEOGRAPHY, 2019 (USD MILLION)
  23. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET, BY SYNTHETIC ACTIVE PHARMACEUTICAL INGREDIENTS SIZE, BY GEOGRAPHY, 2019 (USD MILLION)
  24. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY THERAPEUTIC APPLICATION, 2025 (USD MILLION)
  25. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET, BY CARDIOVASCULAR DISEASES SIZE, BY GEOGRAPHY, 2019 (USD MILLION)
  26. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET, BY COMMUNICABLE DISEASES SIZE, BY GEOGRAPHY, 2019 (USD MILLION)
  27. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET, BY DIABETES SIZE, BY GEOGRAPHY, 2019 (USD MILLION)
  28. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET, BY ONCOLOGY SIZE, BY GEOGRAPHY, 2019 (USD MILLION)
  29. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET, BY PAIN MANAGEMENT SIZE, BY GEOGRAPHY, 2019 (USD MILLION)
  30. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET, BY RESPIRATORY DISEASES SIZE, BY GEOGRAPHY, 2019 (USD MILLION)
  31. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET: FPNV POSITIONING MATRIX
  1. Abbvie Inc.
  2. Astrazeneca
  3. Aurobindo Pharma
  4. BASF SE
  5. Boehringer Ingelheim
  6. Bristol-Myers Squibb
  7. ELI Lilly and Company
  8. F. Hoffmann-La Roche
  9. Glaxosmithkline PLC
  10. Merck & Co., Inc.
  11. Novartis AG
  12. Pfizer, Inc.
  13. Sanofi
  14. Sun Pharmaceutical Industries Ltd
  15. Teva Pharmaceutical Industries Ltd
Global Active Pharmaceutical Ingredient Market
Report Code
MRR-2AA0F85
Publishing Date
April 2020
Number of Pages
170
Available Formats

SELECT LICENSE TYPE

ENTERPRISE USER LICENSE $7949
CORPORATE USER LICENSE $6449
SINGLE USER LICENSE $4949